Aprea Therapeutics, Inc.
▲ 1 upgrades / ▼ 0 downgrades / 0 reiterations from 1 firms
Nov 10, 2026 (15 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 14, 2026 | Ladenburg Thalmann | initiate | — → Buy | — | 45% |
| Aug 13, 2026 | Wedbush | maintain | Outperform → Outperform | — | 58% |
| May 14, 2026 | Wedbush | maintain | Outperform → Outperform | — | 58% |
| May 7, 2026 | Oppenheimer | initiate | — → Outperform | — | 52% |
| Mar 31, 2026 | Wedbush | reiterate | Outperform → Outperform | — | 58% |
| Mar 31, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Feb 10, 2026 | Wedbush | maintain | Outperform → Outperform | $7 | 58% |
| Jan 29, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | $4 | 44% |
| Dec 18, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $5 | 44% |
| Jan 15, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $20 | 44% |
| Dec 17, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $20 | 44% |
| Nov 18, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $20 | 44% |
| Oct 24, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $20 | 44% |
| Aug 13, 2024 | Wedbush | reiterate | Outperform → Outperform | $11 | 58% |
| Aug 12, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $20 | 44% |
| Jun 24, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $20 | 44% |
| Jun 17, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $20 | 44% |
| May 14, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $20 | 44% |
| Mar 27, 2024 | Wedbush | maintain | Outperform → Outperform | $11 | 58% |
| Mar 26, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $20 | 44% |
| Nov 1, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $20 | 44% |
| Sep 13, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $20 | 44% |
| Aug 10, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $20 | 44% |
| May 16, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $20 | 44% |
| Mar 10, 2023 | Maxim Group | initiate | — → Buy | $16 | 42% |
No cross-platform signals in the last 90 days